Home » Topics » Disease categories and therapies » Urology

Urology
RSS

European approval recommended for Emselex

Aug. 3, 2004

Further positive phase I/II data for NX-1207 in BPH

Aug. 2, 2004

Chinese researchers identify novel agents for renal disorders

July 30, 2004

Novel dopamine D3 agonists and their use in sexual disorders

July 29, 2004

INNOVATION study of Micardis completes enrollment

July 28, 2004

Abbott and Deltanoid to develop fourth generation active D therapies

July 27, 2004

FDA extends Fosrenol review

July 22, 2004

Significant association found between coronary artery risk factors and erectile dysfunction

July 20, 2004

Phase II protocol for NX-1207 accepted by FDA

July 19, 2004

Zonagen reports Androxal phase I/II study results

July 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...
Initial data hint that US MFN pricing is hitting access in Europe
BioWorld
There are initial signs that President Donald Trump’s most-favored nation (MFN) policy may be further delaying access to new drugs in Europe, as companies hold...